73 related articles for article (PubMed ID: 9760950)
1. Gliadel wafers for treatment of brain tumors.
Med Lett Drugs Ther; 1998 Sep; 40(1035):92. PubMed ID: 9760950
[No Abstract] [Full Text] [Related]
2. Distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea and tracers in the rabbit brain after interstitial delivery by biodegradable polymer implants.
Strasser JF; Fung LK; Eller S; Grossman SA; Saltzman WM
J Pharmacol Exp Ther; 1995 Dec; 275(3):1647-55. PubMed ID: 8531140
[TBL] [Abstract][Full Text] [Related]
3. Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors.
Sampath P; Hanes J; DiMeco F; Tyler BM; Brat D; Pardoll DM; Brem H
Cancer Res; 1999 May; 59(9):2107-14. PubMed ID: 10232596
[TBL] [Abstract][Full Text] [Related]
4. [Local chemotherapy for brain tumors].
Med Monatsschr Pharm; 2006 Dec; 29(12):460-1. PubMed ID: 17220043
[No Abstract] [Full Text] [Related]
5. Cerebral edema associated with Gliadel wafers: two case studies.
Weber EL; Goebel EA
Neuro Oncol; 2005 Jan; 7(1):84-9. PubMed ID: 15701285
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable polymers for drug delivery to the brain.
Langer R
ASAIO Trans; 1988; 34(4):945-6. PubMed ID: 2851308
[No Abstract] [Full Text] [Related]
7. Brain tumor and Gliadel wafer treatment.
Panigrahi M; Das PK; Parikh PM
Indian J Cancer; 2011; 48(1):11-7. PubMed ID: 21330749
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain.
Fung LK; Ewend MG; Sills A; Sipos EP; Thompson R; Watts M; Colvin OM; Brem H; Saltzman WM
Cancer Res; 1998 Feb; 58(4):672-84. PubMed ID: 9485020
[TBL] [Abstract][Full Text] [Related]
9. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.
Attenello FJ; Mukherjee D; Datoo G; McGirt MJ; Bohan E; Weingart JD; Olivi A; Quinones-Hinojosa A; Brem H
Ann Surg Oncol; 2008 Oct; 15(10):2887-93. PubMed ID: 18636295
[TBL] [Abstract][Full Text] [Related]
10. Carmustine-impregnated wafers and their impact in the management of high-grade glioma.
La Rocca RV; Rezazadeh A
Expert Opin Pharmacother; 2011 Jun; 12(8):1325-1332. PubMed ID: 21548723
[No Abstract] [Full Text] [Related]
11. Treatment of single brain metastasis with resection, intracavity carmustine polymer wafers, and radiation therapy is safe and provides excellent local control.
Ewend MG; Brem S; Gilbert M; Goodkin R; Penar PL; Varia M; Cush S; Carey LA
Clin Cancer Res; 2007 Jun; 13(12):3637-41. PubMed ID: 17575228
[TBL] [Abstract][Full Text] [Related]
12. Beyond the barrier: devices inside the brain.
Williams D
Med Device Technol; 1995 May; 6(4):6-9. PubMed ID: 10155387
[TBL] [Abstract][Full Text] [Related]
13. Drug delivery to tumors of the central nervous system.
Lesniak MS; Langer R; Brem H
Curr Neurol Neurosci Rep; 2001 May; 1(3):210-6. PubMed ID: 11898520
[TBL] [Abstract][Full Text] [Related]
14. Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial.
Olivi A; Grossman SA; Tatter S; Barker F; Judy K; Olsen J; Bruce J; Hilt D; Fisher J; Piantadosi S;
J Clin Oncol; 2003 May; 21(9):1845-9. PubMed ID: 12721262
[TBL] [Abstract][Full Text] [Related]
15. Polymers to treat brain tumours.
Brem H
Biomaterials; 1990 Nov; 11(9):699-701. PubMed ID: 2090306
[TBL] [Abstract][Full Text] [Related]
16. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial.
Westphal M; Ram Z; Riddle V; Hilt D; Bortey E;
Acta Neurochir (Wien); 2006 Mar; 148(3):269-75; discussion 275. PubMed ID: 16482400
[TBL] [Abstract][Full Text] [Related]
17. Role of convective flow in carmustine delivery to a brain tumor.
Arifin DY; Lee KY; Wang CH; Smith KA
Pharm Res; 2009 Oct; 26(10):2289-302. PubMed ID: 19639394
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
[TBL] [Abstract][Full Text] [Related]
19. Carmustine as a cause of acute nonlymphocytic leukemia.
Greene MH; Boice JD; Strike TA
N Engl J Med; 1985 Aug; 313(9):579. PubMed ID: 3894973
[No Abstract] [Full Text] [Related]
20. [Gliadel--a preparation for the supplementary treatment of brain cancer].
Domb A
Harefuah; 1999 Aug; 137(3-4):127-31. PubMed ID: 10959302
[No Abstract] [Full Text] [Related]
[Next] [New Search]
